Cavo, M., Schjesvold, F., Dimopoulos, M., Delforge, M., Escalante, F., Kleinman, D., Lee, H. C., Vij, R., Greil, R., Melchardt, T., Antonioli, E., Lysen, A., Camadoo-O’Byrne, L., Bitetti, J., d’Estrube, T., Fry, M., Byrne, J., Vossen, C. Y., Sapra, S., Benson, V. S., Mouro, J. and Hultcrantz, M. (2020) “Real-world effectiveness and safety of belantamab mafodotin monotherapy in patients with relapsed/refractory multiple myeloma treated in Europe”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.289034.